WST West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About West Pharmaceutical Services (NYSE: WST)
›
West Pharmaceutical Services (NYSE: WST) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 10,000 employees.
The shares were at 396.69 USD on 19 November 2026, up 51.4% over 52 weeks. Its 52-week range is 223.83 USD to 438.26 USD: the price is 9.5% below the high and 77.2% above the low.
At a market capitalisation of 27.63B USD, it trades at 44.5 times trailing earnings and 38.2 times forward earnings. The median trailing P/E of its 18 largest Medical Instruments & Supplies peers is 51.8, a discount of 14% for WST. It pays a dividend yielding 0.26% (it pays out 10% of its earnings), against a median of 1.00% among the dividend payers in that peer group.
West Pharmaceutical Services reports return on equity of 15.5%, an operating margin of 22.9% and revenue up 8.7% year over year.
It holds more cash than debt, a net cash position of 150.20M USD. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 15 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 471.00 USD is 18.7% above the current price. The next earnings report is expected on 18 February 2027.